Trials of opiate antagonists for the pruritus of cholestasis: Primary efficacy endpoints and opioid withdrawal-like reactions

Journal of Hepatology

Volumn 37, Issue 6, 2002, Pages 863-865

  Jones, E Anthony ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NALMEFENE; NALOXONE; OPIATE; OPIATE ANTAGONIST; OPIATE RECEPTOR; OPIATE PEPTIDE;

CENTRAL NERVOUS SYSTEM; CHOLESTASIS; DRUG EFFICACY; DRUG TOLERABILITY; EDITORIAL; HUMAN; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PRURITUS; VISUAL ANALOG SCALE; ANIMAL; DRUG ANTAGONISM; NOTE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ANIMALS; CHOLESTASIS; HUMANS; OPIOID PEPTIDES; PRURITUS; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 0036893765     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00347-1     Document Type: Editorial

References (26)

1. de Quincy T. Confessions of an English opium eater. London Magazine 1821. London: Penguin, 1971.
2. Koenigstein H. Experimental study of itch stimuli in animals. Arch Dermatol Syph 1948;57:828-849.
3. Ballantyne JC, Loach AB, Carr DB. Itching after epidural and spinal opiates. Pain 1988;33:149-160.
4. Thomas DA, Williams GW, Iwata K, Kenshalo Jr DR, Dubner R. Effects of central administration of opioids on facial scratching in monkeys. Brain Res 1992;585:315-317.
5. Bergasa NV, Jones EA. The pruritus of cholestasis. Potential pathogenic and therapeutic implications of opioids. Gastroenterology 1995:108:1582-1588.
6. Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. Br Med J 1988;297:1501-1504.
7. Bergasa NV, Rothman RB, Vergalla J, Xu H, Swain MG, Jones EA. Central mu-opioid receptors are down-regulated in a rat model of acute cholestasis. J Hepatol 1992;15:220-224.
8. Bergasa NV, Alling DW, Vergalla J, Jones EA. Cholestasis in the male rat is associated with naloxone-reversible antinociception. J Hepatol 1994;20:85-90.
9. Jones EA, Bergasa NV. The pruritus of cholestasis. Hepatology 1999;29:1003-1006.
10. Bergasa NV, Talbot TL, Alling DW, Schmitt JM, Walker EC, Baker BL, et al. A controlled trial of naloxone infusions for the pruritus of cholestasis. Gastroenterology 1992;102:544-549.
11. Bergasa NV, Alling DW, Talbot TL, Swain MG, Yurdaydin C, Turner ML, et al. Effects of naloxone infusions in patients with the pruritus of cholestasis: A double-blind, randomised controlled trial. Ann Intern Med 1995;123:161-167.
12. Bergasa NV, Schmitt JM, Talbot TL, Alling DW, Swain MG, Turner ML, et al. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology 1998;27:679-684.
13. Bergasa NV, Alling DW, Talbot TL, Wells MC, Jones EA. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: A controlled study. J Am Acad Dermatol 1999;41:431-434.
14. Wolfhagen FHJ, Sternieri E, Hop WCJ, Vitale G, Bertolotti M, van Buuren HR. Oral naltrexone for cholestatic pruritus: A double-blind, placebo-controlled trial. Gastroenterology 1997;113:1264-1269.
15. Terg R, Coronel E, Sordá J, Muñoz AE, Findor J. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol 2002;37:717-722.
16. McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales: A critical review. Psychol Med 1988;18:1007-1019.
17. Bergasa NV, Alling DW, Talbot T, Schmidt J, Jones EA. Assessment of the pruritus of cholestasis: An appraisal of the visual analog score. Hepatology 1990;12:887.
18. Shelly WB, Arthur RP. The neurohistology and neurophysiology of the itch sensation in man. Arch Dermatol 1957;76:296-323.
19. Felix R, Shuster S. A new method for the measurement of itch and the response to treatment. Br J Dermatol 1975;93:303-312.
20. Summerfield JA, Welch ME. The measurement of itch with sensitive limb movement meters. Br J Dermatol 1980;102:275-281.
21. Talbot TL, Schmitt JM, Bergasa NV, Jones EA, Walker EC. Application of piezofilm technology for the quantitative assessment of pruritus. Biomed Instrum Technol 1991;25:400-403.
22. Molenaar HAJ, Oosting J, Jones EA. Improved device for measuring scratching activity in patients with pruritus. Med Biol Eng Comput 1998;36:220-224.
23. Le Fanu J. Clinical science - A new ideology for medicine. In: The Rise and Fall of Modern Medicine. London: Little Brown and Company, 1999. pp. 196-205.
24. Jones EA, Dekker LRC. Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis. Gastroenterology 2000;118:431-432.
25. Neuberger J, Jones EA. Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy. Eur J Gastroenterol Hepatol 2001;13:1393-1394.
26. Jones EA, Neuberger J, Bergasa NV. Opiate antagonist therapy for the pruritus of cholestasis: The avoidance of opioid withdrawal-like reactions. Q J Med 2002;95:547-552.